InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
64,048.60
(
1.84%
)
Post# of 11554
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

StocksDiva

Send PM Follow Ignore
Followers 378
Posts 20728
Boards Moderated 2
Alias Born 03/28/2010

StocksDiva

Re: StocksDiva post# 9617

Monday, 10/22/2012 7:12:16 AM

Monday, October 22, 2012 7:12:16 AM

Post# of 11554
Synergy Pharmaceuticals (SGYP) announced that on Oct 19, 2012 the co initiated oral dosing of healthy adult volunteers in a Phase I clinical trial of SP-333, a guanylate cyclase C (GC-C) agonist designed to treat ulcerative colitis.

http://finance.yahoo.com/news/synergy-pharmaceuticals-initiates-dosing-healthy-100000379.html

StocksDiva Bio Bin Board...Come say hi!!!



ALWAYS DO YOUR OWN DUE DILIGENCE!!! ALWAYS

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up